ResearcherUniversity of UlsterNo recent work listed

Dean Nicholas

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5053783286. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2021: 1 paper

Papers 1

Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cance… Co-author DOI 10.1016/j.ejpb.2021.03.005 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Keiran A. Logan · 1 shared paper, 2021 · strength 0.11
- Paper Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effe… DOI 10.1016/j.ejpb.2021.03.005 ↗
John F. Callan · 1 shared paper, 2021 · strength 0.11
- Paper Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effe… DOI 10.1016/j.ejpb.2021.03.005 ↗
Nikolitsa Nomikou · 1 shared paper, 2021 · strength 0.11
- Paper Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effe… DOI 10.1016/j.ejpb.2021.03.005 ↗
Paul J Kelly · 1 shared paper, 2021 · strength 0.11
- Paper Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effe… DOI 10.1016/j.ejpb.2021.03.005 ↗
A. P. McHale · 1 shared paper, 2021 · strength 0.11
- Paper Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effe… DOI 10.1016/j.ejpb.2021.03.005 ↗
Heather Nesbitt · 1 shared paper, 2021 · strength 0.11
- Paper Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effe… DOI 10.1016/j.ejpb.2021.03.005 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.